Specialized Pro-Resolving Mediators and the Lymphatic System
Diminished lymphatic function and abnormal morphology are common in chronic inflammatory diseases. Recent studies are investigating whether it is possible to target chronic inflammation by promoting resolution of inflammation, in order to enhance lymphatic function and attenuate disease. Resolution...
Main Authors: | Jamie D. Kraft, Robert Blomgran, Iben Lundgaard, Marianne Quiding-Järbrink, Jonathan S. Bromberg, Emma Börgeson |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/5/2750 |
Similar Items
-
PCOS: A Chronic Disease That Fails to Produce Adequately Specialized Pro-Resolving Lipid Mediators (SPMs)
by: Pedro-Antonio Regidor, et al.
Published: (2022-02-01) -
Chronic Inflammation in PCOS: The Potential Benefits of Specialized Pro-Resolving Lipid Mediators (SPMs) in the Improvement of the Resolutive Response
by: Pedro-Antonio Regidor, et al.
Published: (2020-12-01) -
The Use of Specialized Pro-Resolving Mediators in Biomaterial-Based Immunomodulation
by: Ana Beatriz Sousa, et al.
Published: (2023-04-01) -
Randomized, double-blind, placebo-controlled study to evaluate the effect of treatment with an SPMs-enriched oil on chronic pain and inflammation, functionality, and quality of life in patients with symptomatic knee osteoarthritis: GAUDI study
by: Ingrid Möller, et al.
Published: (2023-06-01) -
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still’s disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles
by: Luca Navarini, et al.
Published: (2023-04-01)